Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03331731 |
| Title | A Phase II Study to Determine Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma (PLIMATH) |
| Acronym | PLIMATH |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Peter MacCallum Cancer Centre, Australia |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | NZL | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Concord Hospital | Concord | New South Wales | 2139 | Australia | Details | |
| Linear Clinical Research | Nedlands | Perth | 6009 | Australia | Details | |
| Royal Brisbane and Women's Hospital | Herston | Queensland | 4029 | Australia | Details | |
| Peter MacCallum Cancer Centre | Melbourne | Victoria | 3000 | Australia | Details | |
| Alfred Health | Melbourne | Victoria | 3004 | Australia | Details | |
| Auckland City Hospital | Auckland | 1023 | New Zealand | Details |